These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Serial Multimodality Imaging and 2-Year Clinical Outcomes of the Novel DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System for the Treatment of Single De Novo Coronary Lesions. Abizaid A; Costa RA; Schofer J; Ormiston J; Maeng M; Witzenbichler B; Botelho RV; Costa JR; Chamié D; Abizaid AS; Castro JP; Morrison L; Toyloy S; Bhat V; Yan J; Verheye S JACC Cardiovasc Interv; 2016 Mar; 9(6):565-74. PubMed ID: 27013155 [TBL] [Abstract][Full Text] [Related]
11. An independent bench comparison of two bioresorbable drug-eluting coronary scaffolds (Absorb and DESolve) with a durable metallic drug-eluting stent (ML8/Xpedition). Ormiston JA; Webber B; Ubod B; Darremont O; Webster MW EuroIntervention; 2015 May; 11(1):60-7. PubMed ID: 25680225 [TBL] [Abstract][Full Text] [Related]
12. In vitro performance investigation of bioresorbable scaffolds - Standard tests for vascular stents and beyond. Schmidt W; Behrens P; Brandt-Wunderlich C; Siewert S; Grabow N; Schmitz KP Cardiovasc Revasc Med; 2016 Sep; 17(6):375-83. PubMed ID: 27266902 [TBL] [Abstract][Full Text] [Related]
13. Is the Dream of Vascular Restoration Still Alive? A Case of 7 Years, Follow-Up After Bioresorbable Vascular Scaffold Implantation. Budassi S; Zivelonghi C; Muyldermans P; Agostoni P; Verheye S Cardiovasc Revasc Med; 2020 Nov; 21(11S):158-161. PubMed ID: 32029391 [TBL] [Abstract][Full Text] [Related]